Detalhe da pesquisa
1.
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis.
Am J Hematol
; 98(4): 588-597, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594185
2.
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Am J Hematol
; 98(6): 848-856, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880203
3.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Cancer
; 128(3): 529-535, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633671
4.
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
Cancer
; 127(7): 1039-1048, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259056
5.
Current Management and New Developments in the Treatment of Myelodysplastic Syndrome.
Cancer Treat Res
; 181: 115-132, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34626358
6.
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.
Curr Treat Options Oncol
; 22(7): 63, 2021 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097131
7.
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Am J Hematol
; 95(10): 1193-1199, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628327
8.
Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.
Biol Blood Marrow Transplant
; 25(8): e260-e267, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926447
9.
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).
Am J Hematol
; 96(6): E196-E200, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719090
10.
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia.
Am J Hematol
; 96(3): E59-E63, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33227142
11.
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 30(2): 229.e1-229.e11, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952648
12.
Autoimmune Hemolytic Anemia in a Patient With COVID-19 Pneumonia: A Case Report on a Rare Presentation.
Cureus
; 15(11): e49067, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125223
13.
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study.
Stem Cell Res Ther
; 14(1): 95, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072867
14.
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab.
Transplant Cell Ther
; 29(5): 314-320, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682470
15.
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience.
Cancer Med
; 12(10): 11248-11253, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081733
16.
Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Transplant Cell Ther
; 29(8): 515.e1-515.e7, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182736
17.
WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens.
Leuk Lymphoma
; 64(11): 1811-1821, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533373
18.
New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT).
Hematology Am Soc Hematol Educ Program
; 2022(1): 74-82, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485163
19.
Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 28(2): 111.e1-111.e8, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844022
20.
Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens.
Bone Marrow Transplant
; 57(2): 232-242, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802049